Strategic Initiative
Slingshot members are tracking this corporate initiative:
Allergan (AGN) Exercises $200MM Option to Acquire Motus Therapeutics and Diabetic Gastroparesis (DG) Drug Relamorelin from Rhythm Holding Company, LLC
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| AGN |
|
|
Motus Therapeutics |
|
|
Rhythm Holding Company |
|
|
Slingshot Insights Explained
Strategic Initiative Date
Announcement Date: Oct 27, 2016 Projected Implementation: Q4, 2016 Relevance Tracked Until: Q4, 2017
Related Projects
-
Don’t see a project related to the strategic initiative you care about?
Related Keywords
Option, Diabetic Gastroparesis, Relamorelin, Acquisition
